Glycosylation changes of IgG associated with rheumatooid arthritis can activate complement via the mannose-binding protein
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
The glycosylation of the circulating immunoglobulin-gamma (IgG) antibody molecules changes in rheumatoid arthritis. The extent of the changes correlates with the disease severity and reverses in remission. We demonstrate here that the alteration in glycosylation associated with rheumatoid arthritis can create a new mode for the interaction of IgG with complement through binding to the collagenous lectin mannose-binding protein (MBP). Rheumatoid arthritis is associated with a marked increases in IgG glycoforms that lack galactose (referred to as G0 glycoforms) in the Fc region of the molecule and that terminate in N-acetyl glucosamine (GlcNAc). We show, using nuclear magnetic resonance (NMR) and X-ray data, that these terminal GlcNAc residues become accessible for MBP binding. We further demonstrate that multiple presentation of IgG-G0 glycoforms to MBP results in activation of the complement. This suggests that a contribution to the chronic inflammation of the synovial membrane could arise from the localization of the IgG-G0 glycoforms in the affected joint and from resulting activation of complement.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Modified Spin-Echo Method for Measuring Nuclear Relaxation Times
Meiboom, S., & Gill, D. (1958) · Review of Scientific Instruments · doi:10.1063/1.1716296 · Cited by 6,022
The hydrolysis of rabbit γ-globulin and antibodies with crystalline papain
Porter, R. R. (1959) · Biochemical Journal · doi:10.1042/bj0730119 · Cited by 2,308
Deisenhofer, J. (1981) · PubMed · Cited by 1,422
Deisenhofer, J. (1981) · Biochemistry · doi:10.1021/bi00512a001 · Cited by 1,333
Parekh, R. B., Dwek, R. A., Sutton, B. J., Fernandes, D. L., Leung, A., Stanworth, D., Rademacher, T. W., Mizuochi, T., Taniguchi, T., Matsuta, K., et al. (1985) · Nature · doi:10.1038/316452a0 · Cited by 1,170
Self-citationStructure of a C-type mannose-binding protein complexed with an oligosaccharide
Weis, W. I., Drickamer, K., & Hendrickson, W. A. (1992) · Nature · doi:10.1038/360127a0 · Cited by 885
The binding site for C1q on IgG
Duncan, A. R., & Winter, G. (1988) · Nature · doi:10.1038/332738a0 · Cited by 569
Drickamer, K., Dordal, M. S., & Reynolds, L. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)62698-0 · Cited by 429
Serum lectin with known structure activates complement through the classical pathway.
Ikeda, K., Sannoh, T., Kawasaki, N., Kawasaki, T., & Yamashina, I. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47587-4 · Cited by 424
Trimeric structure of a C-type mannose-binding protein
Weis, W. I., & Drickamer, K. (1994) · Structure · doi:10.1016/s0969-2126(94)00124-3 · Cited by 307
Research works printed but not linked: 2
- Chang, S.-C. Altered Glycosylation in Immunoglobulin G and Its Fragments in Rheumatoid Arthritis. thesis, Oxford (1993).
- Parekh, R.B. A Study of the Structure and Biosynthesis of N-linked Oligosaccharides and of their Involvement in Certain Diseases. thesis, Oxford Univ.(1987).
Cited by
Fcγ receptors as regulators of immune responses
Nimmerjahn, F., & Ravetch, J. V. (2008) · Nature Reviews Immunology · doi:10.1038/nri2206 · Cited by 2,947
Glycobiology: Toward Understanding the Function of Sugars
Dwek, R. A. (1996) · Chemical Reviews · doi:10.1021/cr940283b · Cited by 2,805
Self-citationVarki, A. (2017) · Glycobiology · doi:10.1093/glycob/cww086 · Cited by 2,635
“Incomplete galactosylation of these glycans has been associated with chronic inflammatory diseases (664) (665) (666) , and there are clear-cut effects of IgG-Fc glycan core fucosylation on antibody-dependent cellular cytotoxicity (667) (668) (669) (670) (671) that are relevant to biotechnology (672) (673) .”
BackgroundShields, R. L., Lai, J., Keck, R., O'Connell, L. Y., Hong, K., Meng, Y. G., Weikert, S. H. A., & Presta, L. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202069200 · Cited by 1,835
Glycosylation and the Immune System
Rudd, P. M., Elliott, T., Cresswell, P., Wilson, I. A., & Dwek, R. A. (2001) · Science · doi:10.1126/science.291.5512.2370 · Cited by 1,588
Self-citationThe Impact of Glycosylation on the Biological Function and Structure of Human Immunoglobulins
Arnold, J. N., Wormald, M. R., Sim, R. B., Rudd, P. M., & Dwek, R. A. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141702 · Cited by 1,307
Self-citationGlycosylation as a strategy to improve antibody-based therapeutics
Jefferis, R. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2804 · Cited by 829
“The serum protein mannose-binding lectin ( MBL ) can recognize and bind arrays of N -acetylglucosamin”
BackgroundIL-6 in autoimmune disease and chronic inflammatory proliferative disease
Ishihara, K., & Hirano, T. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(02)00027-8 · Cited by 807
Mannose-binding lectin: the pluripotent molecule of the innate immune system
Turner, M. (1996) · Immunology Today · doi:10.1016/0167-5699(96)10062-1 · Cited by 735
A Genetic Approach to Mammalian Glycan Function
Lowe, J. B., & Marth, J. D. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161809 · Cited by 594
A Functional Role for Antibodies in Tuberculosis
Lu, L. L., Chung, A. W., Rosebrock, T. R., Ghebremichael, M., Yu, W. H., Grace, P. S., Schoen, M. K., Tafesse, F., Martin, C., Leung, V., et al. (2016) · Cell · doi:10.1016/j.cell.2016.08.072 · Cited by 571
“, 2013) and autoimmune disease (Anthony et al., 2011; Jefferis, 2009; Malhotra et al., 1995;Parekhetal., 1989), antigen-specificAbsaredifferentially glycosylated as a function of disease state and treatment status (Ackerman et al.”
Glycosylation of Recombinant Antibody Therapeutics
Jefferis, R. (2008) · Biotechnology Progress · doi:10.1021/bp040016j · Cited by 526
Anti-Inflammatory Actions of Intravenous Immunoglobulin
Nimmerjahn, F., & Ravetch, J. V. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090232 · Cited by 525
Davis, B. G. (2002) · Chemical Reviews · doi:10.1021/cr0004310 · Cited by 521
Terminal sugars of Fc glycans influence antibody effector functions of IgGs
Raju, T. S. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.06.007 · Cited by 521
Intravenous Immune Globulin in Autoimmune and Inflammatory Diseases
Gelfand, E. W. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1009433 · Cited by 495
Calder, P. C., Bosco, N., Bourdet-Sicard, R., Capuron, L., Delzenne, N., Doré, J., Franceschi, C., Lehtinen, M. J., Recker, T., Salvioli, S., et al. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2017.09.001 · Cited by 488
Karsten, C. M., Pandey, M. K., Figge, J., Kilchenstein, R., Taylor, P. R., Rosas, M., McDonald, J. U., Orr, S. J., Berger, M., Petzold, D., et al. (2012) · Nature Medicine · doi:10.1038/nm.2862 · Cited by 479
Glycans in the immune system and The Altered Glycan Theory of Autoimmunity: A critical review
Maverakis, E., Kim, K., Shimoda, M., Gershwin, M. E., Patel, F., Wilken, R., Raychaudhuri, S., Ruhaak, L. R., & Lebrilla, C. B. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2014.12.002 · Cited by 459
“They also serve as epitopes for lectin binding, including the complement-activating mannose-binding lectins (MBLs) [72].”
BackgroundRaju, T. S., Briggs, J. B., Borge, S. M., & Jones, A. J. S. (2000) · Glycobiology · doi:10.1093/glycob/10.5.477 · Cited by 452
“Changes in N-glycosylation of IgG are associated with the status in diseases such as rheumatoid arthritis (Parekh et al., 1985, 1988; Rademachar et al., 1994; Malhotra et al., 1995).”
BackgroundGarred, P., Pressler, T., Madsen, H. O., Frederiksen, B., Svejgaard, A., Høiby, N., Schwartz, M., & Koch, C. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6861 · Cited by 439
“Likewise , MBL could be involved in the clearance of immune complexes of pathophysiological importance in CF by its interaction with a galactosylated IgG ( 41 ) .”
BackgroundInfluentialHuman IgA Activates the Complement System Via the Mannan-Binding Lectin Pathway
Roos, A., Bouwman, L. H., van Gijlswijk-Janssen, D. J., Faber-Krol, M. C., Stahl, G. L., & Daha, M. R. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.5.2861 · Cited by 431
“This G0-IgG has been shown to bind MBL (40).”
BackgroundGlycosylation: Heterogeneity and the 3D Structure of Proteins
Rudd, P. M., & Dwek, R. A. (1997) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409239709085144 · Cited by 424
Self-citationMannose‐binding lectin and innate immunity
Eddie Ip, W. K., Takahashi, K., Alan Ezekowitz, R., & Stuart, L. M. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00789.x · Cited by 422
“Furthermore, MBL has been implicated in binding agalactose isoforms on antibodies that are found in rheumatoid joint (11), as well as polymeric forms of immunoglobulin A (IgA) (49, 50) and certain glycoforms of M (51).”
BackgroundFc‐Receptors as Regulators of Immunity
Nimmerjahn, F., & Ravetch, J. V. (2007) · Advances in Immunology · doi:10.1016/s0065-2776(07)96005-8 · Cited by 418
Immunoglobulin G glycosylation in aging and diseases
Gudelj, I., Lauc, G., & Pezer, M. (2018) · Cellular Immunology · doi:10.1016/j.cellimm.2018.07.009 · Cited by 408
“Likewise, highly galactosylated immune complexes have been reported to inhibit the pro-inflammatory activity of the complement component C5a [92,99].”
BackgroundOvarian Cancer is Associated with Changes in Glycosylation in Both Acute-Phase Proteins and IgG
Saldova, R., Royle, L., Radcliffe, C. M., Abd Hamid, U. M., Evans, R., Arnold, J. N., Banks, R. E., Hutson, R., Harvey, D. J., Antrobus, R., et al. (2007) · Glycobiology · doi:10.1093/glycob/cwm100 · Cited by 390
“…in rheumatoid arthritis serum (Parekh et al. 1985) and terminal GlcNAc of this glycoform on the Fc region of the IgG molecule clustered, for example on synovial tissue, can be recognized by the serum lectin mannose-binding protein (MBL) resulting in complement activation (Malhotra et al. 1995).”
BackgroundSelf-citationGabius, H. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.t01-1-00543.x · Cited by 379
Pathophysiological advances in membranous nephropathy: time for a shift in patient's care
Ronco, P., & Debiec, H. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60731-0 · Cited by 369
Dekkers, G., Treffers, L., Plomp, R., Bentlage, A. E. H., de Boer, M., Koeleman, C. A. M., Lissenberg-Thunnissen, S. N., Visser, R., Brouwer, M., Mok, J. Y., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00877 · Cited by 356
“It has been proposed for a long time that agalactosylated IgG activates complement more efficiently through the lectin pathway (MBL) (25).”
BackgroundMannose‐binding lectin in innate immunity: past, present and future
Dommett, R. M., Klein, N., & Turner, M. W. (2006) · Tissue Antigens · doi:10.1111/j.1399-0039.2006.00649.x · Cited by 342
“reported that changes in IgG glycosylation secondary to the underlying disease results in MBL-associated complement activation (110).”
BackgroundGalactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG
Tomana, M., Matoušovic, K., Julian, B. A., Radl, J., Konecný, K., & Mestecky, J. (1997) · Kidney International · doi:10.1038/ki.1997.361 · Cited by 341
Jefferis, R., Lund, J., & Pound, J. D. (1998) · Immunological Reviews · doi:10.1111/j.1600-065x.1998.tb01188.x · Cited by 329
The complement system in systemic autoimmune disease
Chen, M., Daha, M. R., & Kallenberg, C. G. M. (2010) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.11.014 · Cited by 327
“Changes in glycosylation of IgG in RA cause an increase in binding of mannose-binding lectin resulting in increased complement activation [117].”
BackgroundThe Immunoregulatory Roles of Antibody Glycosylation
Jennewein, M. F., & Alter, G. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.02.004 · Cited by 323
Ledue, T. B., Weiner, D. L., Sipe, J. D., Poulin, S. E., Collins, M. F., & Rifai, N. (1998) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1177/000456329803500607 · Cited by 321
Effect of glycosylation on antibody function: implications for genetic engineering
Wright, A., & Morrison, S. L. (1997) · Trends in Biotechnology · doi:10.1016/s0167-7799(96)10062-7 · Cited by 312
Vu, V. P., Gifford, G. B., Chen, F., Benasutti, H., Wang, G., Groman, E. V., Scheinman, R., Saba, L., Moghimi, S. M., & Simberg, D. (2019) · Nature Nanotechnology · doi:10.1038/s41565-018-0344-3 · Cited by 309
Evaluation of the serum N ‐linked glycome for the diagnosis of cancer and chronic inflammation
Arnold, J. N., Saldova, R., Hamid, U. M. A., & Rudd, P. M. (2008) · PROTEOMICS · doi:10.1002/pmic.200800163 · Cited by 307
“In vitro the innate serum protein, mannan binding lectin (MBL), can activate the complement cascade via bound serine proteases (MASPs) when bound to clustered IgG-G0 glycoforms [63].”
BackgroundSelf-citationHuhn, C., Selman, M. H. J., Ruhaak, L. R., Deelder, A. M., & Wuhrer, M. (2009) · PROTEOMICS · doi:10.1002/pmic.200800715 · Cited by 301
“In the following, a role has been suggested for the mannose-binding protein in complement activation by IgG-G0 glycoforms in RA [13].”
BackgroundThe collectins in innate immunity
Epstein, J., Eichbaum, Q., Sheriff, S., & Ezekowitz, R. A. B. (1996) · Current Opinion in Immunology · doi:10.1016/s0952-7915(96)80101-4 · Cited by 291
Qian, J., Liu, T., Yang, L., Daus, A., Crowley, R., & Zhou, Q. (2007) · Analytical Biochemistry · doi:10.1016/j.ab.2007.01.023 · Cited by 291
Rombouts, Y., Ewing, E., van de Stadt, L. A., Selman, M. H. J., Trouw, L. A., Deelder, A. M., Huizinga, T. W. J., Wuhrer, M., van Schaardenburg, D., Toes, R. E. M., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-203565 · Cited by 288
Antibody‐mediated modulation of immune responses
Nimmerjahn, F., & Ravetch, J. V. (2010) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00910.x · Cited by 285
van de Geijn, F. E., Wuhrer, M., Selman, M. H., Willemsen, S. P., de Man, Y. A., Deelder, A. M., Hazes, J. M., & Dolhain, R. J. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2892 · Cited by 274
“Secondly, the pathogenicity of agalactosyl IgG is thought to be associated with its ability to activate the complement pathway via binding to mannose-binding lectin (MBL) [18].”
BackgroundVučković, F., Krištić, J., Gudelj, I., Teruel, M., Keser, T., Pezer, M., Pučić‐Baković, M., Štambuk, J., Trbojević‐Akmačić, I., Barrios, C., et al. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39273 · Cited by 269
“Glycan structure FA2[3]G1 (GP9) had the highest predictive power in each analyzed population, and structure FA2B (GP6) was the second strongest predictor, while structures FA2G2”
InfluentialComplement in health and disease
Carroll, M. V., & Sim, R. B. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.06.005 · Cited by 266
Self-citationBondt, A., Rombouts, Y., Selman, M. H. J., Hensbergen, P. J., Reiding, K. R., Hazes, J. M. W., Dolhain, R. J. E. M., & Wuhrer, M. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m114.039537 · Cited by 264
Trouw, L. A., Haisma, E. M., Levarht, E. W. N., van der Woude, D., Ioan‐Facsinay, A., Daha, M. R., Huizinga, T. W. J., & Toes, R. E. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24622 · Cited by 264
Agalactosylated IgG antibodies depend on cellular Fc receptors for in vivo activity
Nimmerjahn, F., Anthony, R. M., & Ravetch, J. V. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702936104 · Cited by 253
Engineering of therapeutic antibodies to minimize immunogenicity and optimize function
Presta, L. G. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.01.026 · Cited by 246
Mannan-binding lectin: clinical significance and applications
Kilpatrick, D. (2002) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(02)00321-5 · Cited by 246
Ercan, A., Cui, J., Chatterton, D. E. W., Deane, K. D., Hazen, M. M., Brintnell, W., O'Donnell, C. I., Derber, L. A., Weinblatt, M. E., Shadick, N. A., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27533 · Cited by 245
Self-citationRole of Oligosaccharide Residues of IgG1-Fc in FcγRIIb Binding
Mimura, Y., Sondermann, P., Ghirlando, R., Lund, J., Young, S. P., Goodall, M., & Jefferis, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107478200 · Cited by 236
Eon‐Duval, A., Broly, H., & Gleixner, R. (2012) · Biotechnology Progress · doi:10.1002/btpr.1548 · Cited by 234
Arnold, J. N., Wormald, M. R., Suter, D. M., Radcliffe, C. M., Harvey, D. J., Dwek, R. A., Rudd, P. M., & Sim, R. B. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504528200 · Cited by 233
Self-citationN-glycomic biomarkers of biological aging and longevity: A link with inflammaging
Dall’Olio, F., Vanhooren, V., Chen, C. C., Slagboom, P. E., Wuhrer, M., & Franceschi, C. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2012.02.002 · Cited by 231
Glycotherapy: New Advances Inspire a Reemergence of Glycans in Medicine
Hudak, J. E., & Bertozzi, C. R. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2013.09.010 · Cited by 231
“It was further shown that this conserved N-glycan at Asn297 of the Fc moiety was essential for binding to Fc receptors (Nimmerjahn and Ravetch, 2005), mannose-binding lectin (Malhotra et al., 1995), and the collectin-related molecule C1q (Raju, 2008).”
BackgroundCorper, A. L., Sohi, M. K., Bonagura, V. R., Steinitz, M., Jefferis, R., Feinstein, A., Beale, D., Taussig, M. J., & Sutton, B. J. (1997) · Nature Structural & Molecular Biology · doi:10.1038/nsb0597-374 · Cited by 224
Antibody fucosylation differentially impacts cytotoxicity mediated by NK and PMN effector cells
Peipp, M., Lammerts van Bueren, J. J., Schneider-Merck, T., Bleeker, W. W. K., Dechant, M., Beyer, T., Repp, R., van Berkel, P. H. C., Vink, T., van de Winkel, J. G. J., et al. (2008) · Blood · doi:10.1182/blood-2008-03-144600 · Cited by 222
Interaction sites on human IgG-Fc for FcγR: current models
Jefferis, R., & Lund, J. (2002) · Immunology Letters · doi:10.1016/s0165-2478(02)00019-6 · Cited by 220
Zhang, P., Woen, S., Wang, T., Liau, B., Zhao, S., Chen, C., Yang, Y., Song, Z., Wormald, M. R., Yu, C., et al. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.01.006 · Cited by 213
Self-citationRole of IgG3 in Infectious Diseases
Damelang, T., Rogerson, S. J., Kent, S. J., & Chung, A. W. (2019) · Trends in Immunology · doi:10.1016/j.it.2019.01.005 · Cited by 213
Pinho, S. S., Alves, I., Gaifem, J., & Rabinovich, G. A. (2023) · Cellular & Molecular Immunology · doi:10.1038/s41423-023-01074-1 · Cited by 206
The Role of Complement in Membranous Nephropathy
Ma, H., Sandor, D. G., & Beck, L. H. (2013) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2013.08.004 · Cited by 197
The history of IgG glycosylation and where we are now
Cobb, B. A. (2020) · Glycobiology · doi:10.1093/glycob/cwz065 · Cited by 193
“Then in the following year, exciting findings based on a combination of X-ray and NMR data were published showing that the agalactosylated IgG glycoforms with terminal GlcNAc residues are able to bind the mannose-binding lectin (MBP), and thus selectively activate the lectin-arm of complement (Malhotra et al. 1995).”
BackgroundGlycoproteins and Their Relationship to Human Disease
Brockhausen, I., Schutzbach, J., & Kuhns, W. (1998) · Cells Tissues Organs · doi:10.1159/000046450 · Cited by 190
“In contrast, the binding of mannose-binding protein to undergalactosylated IgG, followed by complement activation, is increased [Malhotra et al., 1995].”
BackgroundAssociation Between Mannose-Binding Lectin and Vascular Complications in Type 1 Diabetes
Hansen, T. K., Tarnow, L., Thiel, S., Steffensen, R., Stehouwer, C. D. A., Schalkwijk, C. G., Parving, H., & Flyvbjerg, A. (2004) · Diabetes · doi:10.2337/diabetes.53.6.1570 · Cited by 187
“Under normal circumstances circulating MBL does not react with the host’s own tissues (35), but changes in cell surface glycosylations after cellular hypoxia may lead to increased MBL deposition and complement activation (36).”
BackgroundNMR analysis demonstrates immunoglobulin G N-glycans are accessible and dynamic
Barb, A. W., & Prestegard, J. H. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.511 · Cited by 186
Antibody glycosylation in inflammation, disease and vaccination
Alter, G., Ottenhoff, T. H. M., & Joosten, S. A. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2018.05.003 · Cited by 186
“However lack of galactosylation may also make GlcNAc residues more accessible for mannose-binding protein (MBP) binding and thus activation of the alternative complement cascade [55].”
BackgroundMechanisms of disease: The human N-glycome
Lauc, G., Pezer, M., Rudan, I., & Campbell, H. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2015.10.016 · Cited by 184
“Likewise immune complexes rich in galactose residues have been found to inhibit the pro-inflammatory activity of the complement component C5a [54, 55].”
BackgroundEndo, M. (1998) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/13.8.1984 · Cited by 182
Mannose-Binding Lectin (MBL) in Health and Disease
Turner, M. W. (1998) · Immunobiology · doi:10.1016/s0171-2985(98)80037-5 · Cited by 180
Nimmerjahn, F., & Ravetch, J. V. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_86 · Cited by 180
Seeling, M., Brückner, C., & Nimmerjahn, F. (2017) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2017.146 · Cited by 179
Haddad, G., Lorenzen, J. M., Ma, H., de Haan, N., Seeger, H., Zaghrini, C., Brandt, S., Kölling, M., Wegmann, U., Kiss, B., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci140453 · Cited by 177
“In rheumatoid arthritis, galactose-deficient IgG glycoforms have been shown to directly bind MBL (17).”
BackgroundInfluentialThe mannose-binding lectin: a prototypic pattern recognition molecule
Takahashi, K., Ip, W. E., Michelow, I. C., & Ezekowitz, R. A. B. (2006) · Current Opinion in Immunology · doi:10.1016/j.coi.2005.11.014 · Cited by 175
“Agalactosyl IgG [61–63]”
Glycoproteomic Analysis of Antibodies
Zauner, G., Selman, M. H. J., Bondt, A., Rombouts, Y., Blank, D., Deelder, A. M., & Wuhrer, M. (2013) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r112.026005 · Cited by 172
Complement activation by (auto-) antibodies
Daha, N. A., Banda, N. K., Roos, A., Beurskens, F. J. M., Bakker, J. M., Daha, M. R., & Trouw, L. A. (2011) · Molecular Immunology · doi:10.1016/j.molimm.2011.04.024 · Cited by 171
Human IgG4: a structural perspective
Davies, A. M., & Sutton, B. J. (2015) · Immunological Reviews · doi:10.1111/imr.12349 · Cited by 170
Sialylation converts arthritogenic IgG into inhibitors of collagen-induced arthritis
Ohmi, Y., Ise, W., Harazono, A., Takakura, D., Fukuyama, H., Baba, Y., Narazaki, M., Shoda, H., Takahashi, N., Ohkawa, Y., et al. (2016) · Nature Communications · doi:10.1038/ncomms11205 · Cited by 170
“Consistent with previous reports16, the frequencies of terminally sialylated glycoforms, G1FS1 (peak 1), G2FS1 (peak 2), and G2FS2 (peak 4) were equivalently reduced in both IgG1 ACPA and total IgG1 from RA patients compared with total IgG1 from healthy donors; no difference was found between ACPA and total IgG1 from…”
InfluentialMembranous nephropathy: from models to man
Beck, L. H., & Salant, D. J. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72270 · Cited by 169
“MBL has been shown to activate complement in patients with rheumatoid arthritis by binding to a glycan on the Fc portion of IgG that is deficient in terminal galactose, thus exposing GlcNAc (75).”
Bondt, A., Selman, M. H. J., Deelder, A. M., Hazes, J. M. W., Willemsen, S. P., Wuhrer, M., & Dolhain, R. J. E. M. (2013) · Journal of Proteome Research · doi:10.1021/pr400589m · Cited by 168
Complement in the Initiation and Evolution of Rheumatoid Arthritis
Holers, V. M., & Banda, N. K. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01057 · Cited by 168
“The LP pathway component, MBL was shown to be associated with the pathogenicity of agalactosyl IgG (159).”
BackgroundInflammaging and human longevity in the omics era
Monti, D., Ostan, R., Borelli, V., Castellani, G., & Franceschi, C. (2017) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.12.008 · Cited by 167
Mannan binding lectin and its interaction with immunoglobulins in health and in disease
Arnold, J. N., Dwek, R. A., Rudd, P. M., & Sim, R. B. (2006) · Immunology Letters · doi:10.1016/j.imlet.2006.05.007 · Cited by 165
Self-citationButler, M., Quelhas, D., Critchley, A. J., Carchon, H. A., Hebestreit, H. F., Hibbert, R. G., Vilarinho, L., Teles, E. L., Matthijs, G., Schollen, E., et al. (2003) · Glycobiology · doi:10.1093/glycob/cwg079 · Cited by 164
“…the stability of IgG toward proteases, (Leatherbarrow and Dwek, 1984) to decrease the affinity for the Fcg receptor on monocytes (Leatherbarrow et al., 1985), and to provide a potential epitope for the mannose receptor and, if multiply presented, for mannose-binding lectin (Malhotra et al., 1995).”
BackgroundSelf-citationDeane, K. D., Norris, J. M., & Holers, V. M. (2010) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2010.02.001 · Cited by 163
Banda, N. K., Thurman, J. M., Kraus, D., Wood, A., Carroll, M. C., Arend, W. P., & Holers, V. M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.3.1904 · Cited by 153
“The mechanisms by which these target organspecific mAbs bypass the requirements for engagement of the classical pathway remain to be defined but do not appear to involve a lack of alternative pathway regulatory proteins.”
BackgroundInfluentialFc-Glycosylation of IgG1 is Modulated by B-cell Stimuli
Wang, J., Balog, C. I. A., Stavenhagen, K., Koeleman, C. A. M., Scherer, H. U., Selman, M. H. J., Deelder, A. M., Huizinga, T. W. J., Toes, R. E. M., & Wuhrer, M. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m110.004655 · Cited by 162
“Given that reduced galactosylation/sialylation levels or the presence of an additional bisecting GlcNAc could lead to increased proinflammatory activity of IgG (7-12, 16), our data indicate that IgGs produced by ASCs in the presence of IL-21/CpG bear different effector functions as compared to those produced in the pr…”
BackgroundInfluentialSaldova, R., Wormald, M. R., Dwek, R. A., & Rudd, P. M. (2008) · Disease Markers · doi:10.1155/2008/601583 · Cited by 162
“mannose-binding protein (MBL) resulting in complement activation [89].”
Self-citationGreen, R. S., Stone, E. L., Tenno, M., Lehtonen, E., Farquhar, M. G., & Marth, J. D. (2007) · Immunity · doi:10.1016/j.immuni.2007.06.008 · Cited by 162
“Other glycans from various sources that include chitin, N-acetylglucosamine residues, and fragments of hyaluronan also activate the innate immune system and may in some cases contribute to disease pathogenesis (Malhotra et al., 1995; Jiang et al., 2006; Reese et al., 2007).”
BackgroundN-Glycosylation and Inflammation; the Not-So-Sweet Relation
Radovani, B., & Gudelj, I. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.893365 · Cited by 162
Ballanti, E., Perricone, C., Greco, E., Ballanti, M., Di Muzio, G., Chimenti, M. S., & Perricone, R. (2013) · Immunologic Research · doi:10.1007/s12026-013-8422-y · Cited by 161
“IgG glycosylation cause an increase in binding of MBL resulting in increased complement activation [81].”
BackgroundThe N-glycosylation of immunoglobulin G as a novel biomarker of Parkinson's disease
Russell, A. C., Šimurina, M., Garcia, M., Novokmet, M., Wang, Y., Rudan, I., Campbell, H. J., Lauc, G., Thomas, M. G., & Wang, W. (2017) · Glycobiology · doi:10.1093/glycob/cwx022 · Cited by 161
“In rheumatoid arthritis, MBL recognises clusters of agalactosylated IgG within the synovial joints and activates the lectin complement cascade which contributes to inflammation by damaging the surrounding tissue (Arnold et al., 2007).”
BackgroundInfluentialComplement activation following oxidative stress
Collard, C. D., Lekowski, R. W., Jordan, J. E., Agah, A., & Stahl, G. L. (1999) · Molecular Immunology · doi:10.1016/s0161-5890(99)00116-9 · Cited by 160
“Although MBL does not normally recognize the body's own tissues (Malhotra et al., 1995), cellular hypoxia and oxygenderived free radical formation may alter endothelial surface protein expression (Ogawa et al.”
BackgroundThe immunoglobulin, IgG Fc receptor and complement triangle in autoimmune diseases
Karsten, C. M., & Köhl, J. (2012) · Immunobiology · doi:10.1016/j.imbio.2012.07.015 · Cited by 158
“Importantly, bypass pathways exist, in which the C1 omplex activation by IC results in direct cleavage of C3 by the alterative pathway without C2 (Matsushita and Okada 1986) or C4 and 2 cleavage (May and Frank 1973a,b,c).”
BackgroundMannose‐binding protein genetic polymorphisms in black patients with systemic lupus erythematosus
Sullivan, K. E., Wooten, C., Goldman, D., & Petri, M. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780391214 · Cited by 158
Wright, A., & Morrison, S. L. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.7.3393 · Cited by 158
Structural glycobiology: A game of snakes and ladders
DeMarco, M. L., & Woods, R. J. (2008) · Glycobiology · doi:10.1093/glycob/cwn026 · Cited by 156
“…(Coppo and Amore 2004; Moura et al. 2004), inflammatory bowel disease (Campbell et al. 2001), and rheumatoid arthritis (Parekh et al. 1985; Malhotra et al. 1995), there is a growing interest in exploiting these variations in the development of therapeutics (Lo-Man et al. 2004; Buskas et…”
Background
Metadata
- Authors
- Malhotra, R., Wormald, M. R., Rudd, P. M., Fischer, P. B., Dwek, R. A., & Sim, R. B.
- Affiliations
- University of Oxford (GB)
- Venue
- Nature Medicine
- Published
- 1995-03
- Volume
- 1
- Issue
- 3
- Pages
- 237-243
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2053863608
- Cited by
- 786
- References
- 33
- Citations by year
- 2026: 14 · 2025: 18 · 2024: 21 · 2023: 17 · 2022: 34 · 2021: 29 · 2020: 25 · 2019: 32 · 2018: 35 · 2017: 34 · 2016: 32 · 2015: 27 · 2014: 36 · 2013: 36 · 2012: 29
- FWCI
- 8.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Keywords
- rheumatoid arthritis, IgG glycosylation, mannose-binding protein, complement activation, Fc fragment, N-acetylglucosamine, synovitis, chronic inflammation
- MeSH terms
- Arthritis, Rheumatoid, Carbohydrate Sequence, Carrier Proteins, Complement Activation, Computer Simulation, Glycosylation, Humans, Immunoglobulin G, Immunoglobulin Fc Fragments, Models, Molecular, Molecular Sequence Data, Magnetic Resonance Spectroscopy, Synovial Fluid, Mannose-Binding Lectins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.